Litcius/Paper detail

Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse

Laura F. Newell, Todd Williams, James Liu, Yun Yu, Yiyi Chen, Georgeann Booth, Rebekah J. Knight, Kelli Goslee, Rachel J. Cook, Jessica Leonard, Gabrielle Meyers, Elie Traer, Richard D. Press, Guang Fan, Ying Wang, Philipp W. Raess, Richard T. Maziarz, Jennifer Dunlap

2021Transplantation and Cellular Therapy30 citationsDOI

Topics & Concepts

MedicineTransplantationHematopoietic stem cell transplantationHaematopoiesisImmunologyGraft-versus-host diseaseCohortStem cellInternal medicineOncologyBiologyGeneticsAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia research
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse | Litcius